2020 “Yinhua Fund Cup” Sina bank financial planner competition, hot registration. From now on to September 7, you will receive free gift packages worth more than 700 yuan from Guan Qingyou, Luo Yuanshang, Chen Kaifeng and Jian Qi. < p > < p > < p > < p > “science and technology innovation board daily” (Shenzhen, reporter Mo Qingzhen) reported that Wuhan Keqian biological Co., Ltd. (hereinafter referred to as “keqianbio”) was a blow in the face of the failure of registration results. < p > < p > on August 19, according to the information on the official website of the Shanghai Stock Exchange, keqianbio responded to the letter on the implementation of supplementary feedback opinions on the issuance and registration process and disclosed relevant contents, but the audit status of the company’s IPO was still “submitted for registration”. On the same day, the reporter of science and technology innovation board daily learned from the official website of China Securities Regulatory Commission that the issuance Supervision Department of China Securities Regulatory Commission issued a decision on the issuance of warning letters to supervise pre industrial organisms. < / P > < p > the decision pointed out that, after investigation, the CSRC found that during the process of applying for the initial public offering of shares on the science and technology innovation board, the company did not disclose that during the period from 2016 to 2017, the funds were transferred from the company’s account to the financial director’s personal card through disbursing research and development expenses or other expenses, which were used to pay part of executive compensation, bonus or non note free expenses; Li Ming of employees was not disclosed Yishi is the actual operator of Jinhua Kangshun; in the application materials submitted for the first time, it did not fully reveal the risk of performance fluctuation caused by African swine plague. < p > < p > in accordance with Article 74 of the measures for the registration and administration of initial public offering of stocks on the science and technology innovation board (for Trial Implementation), if the issuers, sponsors and securities service institutions have “unclear description of the content of the document disclosure, confusion in logic, seriously affecting the understanding of investors”, “failing to report in time or failing to disclose major matters in time”, the CSRC may consider the circumstances as light as possible In addition, the CSRC has decided to take administrative supervision and management measures to issue warning letters to pre scientific organisms. < / P > < p > it is worth mentioning that keqianbio is one of the first batch of enterprises to apply for science and technology innovation board. Its IPO application was approved by the municipal Party committee meeting as early as October 21, 2019, and was submitted for registration on October 28 of that year. However, nearly 10 months have passed, but its registration and issuance has not yet come to fruition. At the moment of uncertainty in registration, a warning letter from the Securities Regulatory Commission (SFC) floated in, and whether it could successfully obtain the “pass” of the science and technology innovation board seems to be more complicated. < p > < p > there has been a precedent of not being registered. For the first case, HengAn Jiaxin was issued a warning letter due to the inconsistency and substantial difference of information disclosure related to revenue recognition of major contracts. < / P > < p > on August 20, the reporter tried to contact pre division biology, hoping to further understand its response plan and audit progress, but it failed to reach the deadline; the company also did not reply to the interview letter. Wang Jiyue, a senior investment banker, analyzed to the reporter of the science and technology innovation board daily that there is no provision in the laws and regulations that the administrative supervision measures taken mean that they will not be registered. There are also cases in the first batch of enterprises that have been punished but released. However, Shen Meng, executive director of Xiangsong capital, believes that although there is no explicit punishment affecting registration, the registration system requires that listed companies should not have potential legal disputes or risks, so they may not be registered until the relevant problems are solved. “The problem is completely solved before the normal process can be restored.” Its representation. < p > < p > < p > < p > the reporter of the science and technology innovation board daily noted that among the enterprises applying for the science and technology innovation board, it was rare to receive feedback letters in the issuance and registration process, with less than 10 companies in total, and the pre scientific biology was one of them. < p > < p > on August 19, according to the reply to the inquiry letter disclosed by Keqian biology, the regulatory authorities still raised five major problems to the company in the registration process, mainly involving the authenticity of customers, the technical property rights and authorization of main products, and the contribution of authorized patents to human income and profit.